Rho-mediated regulation of TGF-β1-and FGF-2-induced activation of corneal stromal keratocytes

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 8, 2009, Pages 3662-3670

  Chen, Jian ^a   Guerriero, Emily ^a   Sado, Yoshikazu ^b   Sundarraj, Nirmala ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Shigei Medical Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; EXOENZYME C3; FIBROBLAST GROWTH FACTOR 2; KERATOCAN; LUMICAN; MESSENGER RNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; AMIDE; BOTULINUM TOXIN; ENZYME INHIBITOR; EXOENZYME C3, CLOSTRIDIUM BOTULINUM; KERATAN SULFATE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PYRIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CORNEA CELL; CORNEA STROMA; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; FIBROBLAST; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACTINS; ADP RIBOSE TRANSFERASES; AMIDES; ANIMALS; BLOTTING, WESTERN; BOTULINUM TOXINS; CELL CULTURE TECHNIQUES; COLLAGEN TYPE IV; CORNEAL STROMA; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; KERATAN SULFATE; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; PYRIDINES; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 68349114970     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3276     Document Type: Article

References (55)

1. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res. 2000;19:113-129.
2. Klenkler B, Sheardown H, Jones L. Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology. Ocul Surf. 2007;5:228-239.
3. Netto MV, Mohan RR, Ambrosio R Jr, Hutcheon AE, Zieske JD, Wilson SE. Wound healing in the cornea: a review of refractive surgery complications and new prospects for therapy. Cornea. 2005;24:509-522.
4. Stramer BM, Fini ME. Uncoupling keratocyte loss of corneal crystalline from markers of fibrotic repair. Invest Ophthalmol Vis Sci. 2004;45:4010-4015.
5. West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol. 2006;38: 1625-1631.
6. Narumiya S, Ishizaki T, Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 1997;410:68-72.
7. Narumiya S. Cellular functions and pharmacological manipulations of the small GTPase Rho & Rho effectors (in Japanese). Nippon Yakurigaku Zasshi. 1999;114(suppl 1):1P-5P.
8. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998; 279:509-514.
9. Hall A, Nobes CD. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci. 2000;355:965-970.
10. Kato T, Nakayasu K, Kanai A. Corneal wound healing: immunohistological features of extracellular matrix following penetrating keratoplasty in rabbits. Jpn J Ophthalmol. 2000;44:334-341.
11. Ljubimov AV, Alba SA, Burgeson RE, et al. Extracellular matrix changes in human corneas after radial keratotomy. Exp Eye Res. 1998;67:265-272.
12. Melles GRJ, SundarRaj N, Binder PS, et al. Immunohistochemical analysis of unsutured and sutured corneal wound-healing. Curr Eye Res. 1995;14:809-817.
13. SundarRaj N, Martin J, Hrinya N. Development and characterization of monoclonal antibodies to human type III procollagen. Biochem Biophys Res Commun. 1982;106:48-57.
14. SundarRaj N, Geiss MJ, III, Fantes F, et al. Healing of excimer laser ablated monkey corneas: an immunohistochemical evaluation. Arch Ophthalmol. 1990;108:1604-1610.
15. Vansetten GB, Koch JW, Tervo K, et al. Expression of tenascin and fibronectin in the rabbit cornea after excimer laser-surgery. Graefes Arch Clin Exp Ophthalmol. 1992;230:178-183.
16. Mulholland B, Tuft SJ, Khaw PT. Matrix metalloproteinase distribution during early corneal wound healing. Eye. 2005;19:584-588.
17. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002; 21:1-14.
18. Ye HQQ, Maeda M, Yu FSX, Azar DT. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41: 2894-2899.
19. Azar DT, Hahn TW, Jain S, Yeh YC, Stetler-Stevensen WG. Matrix metalloproteinases are expressed during wound healing after excimer laser keratectomy. Cornea. 1996;15:18-24.
20. Fini ME, Girard MT, Matsubara M, Bartlett JD. Unique regulation of the matrix metalloproteinase, gelatinase-B. Invest Ophthalmol Vis Sci. 1995;36:622-633.
21. Fini ME, Girard MT, Matsubara M. Collagenolytic gelatinolytic enzymes in corneal wound-healing. Acta Ophthalmol. 1992;70: 26-33.
22. Carlson EC, Wang IJ, Liu CY, Brannan P, Kao CWC, Kao WWY. Altered KSPG expression by keratocytes following corneal injury. Mol Vis. 2003;9:615-623.
23. Funderburgh JL. Keratan sulfate: structure, biosynthesis, and function. Glycobiology. 2000;10:951-958.
24. SundarRaj N, Fite D, Belak R, et al. Proteoglycan distribution during healing of corneal stromal wounds in chick. Exp Eye Res. 1998;67:433-442.
25. Berryhill BL, Beales MP, Hassell JR. Production of prostaglandin D synthase as a keratan sulfate proteoglycan by cultured bovine keratocytes. Invest Ophthalmol Vis Sci. 2001;42:1201-1207.
26. Guerriero E, Chen J, Sado Y, et al. Loss of alpha3(IV) collagen expression associated with corneal keratocyte activation. Invest Ophthalmol Vis Sci. 2007;48:627-635.
27. Jester JV, Møller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci. 1999;112:613-622.
28. Kirschner SE, Ciaccia A, Ubels JL. The effect of retinoic acid on thymidine incorporation and morphology of corneal stromal fibroblasts. Curr Eye Res. 1990;9:1121-1125.
29. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
30. Jester JV, Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003;77: 581-592.
31. Jester JV, Budge A, Fisher S, Huang J. Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering 1. Invest Ophthalmol Vis Sci. 2005;46: 2369-2378.
32. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 2007;29:356-370.
33. Tatsuno I, Hirai A, Saito Y. Cell-anchorage, cell cytoskeleton, and Rho-GTPase family in regulation of cell cycle progression. Prog Cell Cycle Res. 2000;4:19-25.
34. Toksoz D, Merdek KD. The Rho small GTPase: functions in health and disease. Histol Histopathol. 2002;17:915-927.
35. Schmandke A, Schmandke A, Strittmatter SM. ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist. 2007;13:454-469.
36. Anderson SC, SundarRaj N. Regulation of a rho-associated kinase expression during the corneal epithelial cell cycle. Invest Ophthalmol Vis Sci. 2001;42:933-940.
37. SundarRaj N, Willson J, Gregory JD, Damle SP. Monoclonal antibodies to proteokeratan sulfate of rabbit corneal stroma. Curr Eye Res. 1985;4:49-54.
38. Gutkind JS. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 1998;17: 1331-1342.
39. Ling L, Lobie PE. RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription. J Biol Chem. 2004;279:32737-32750.
40. Meyer-ter-Vehn T, Sieprath S, Katzenberger B, Gebhardt S, Grehn F, Schlunck G. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human Tenon fibroblasts. Invest Ophthalmol Vis Sci. 2006;47:4895-4904.
41. Tura A, Grisanti S, Petermeier K, Henke-Fahle S. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro. Invest Ophthalmol Vis Sci. 2007;48:2152-2161.
42. Masamune A, Kikuta K, Satoh M, Satoh K, Shimosegawa T. Rho kinase inhibitors block activation of pancreatic stellate cells. Br J Pharmacol. 2003;140:1292-1302.
43. Smith PC, Caceres M, Martinez J. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways. J Periodontal Res. 2006;41:418-425.
44. Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P. Profiling molecular targets of TGF-beta1 in prostate fibroblast-omyofibroblast transdifferentiation. Mech Ageing Dev. 2005;126: 59-69.
45. arvey KA, Paranavitana CN, Zaloga GP, Siddiqui RA. Diverse signaling pathways regulate fibroblast differentiation and transformation through Rho kinase activation. J Cell Physiol. 2007;211: 353-363.
46. Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int. 2007;31:1225-1230.
47. Masszi A, Di CC, Sirokmany G, et al. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol. 2003;284:F911-F924.
48. Anderson S, DiCesare L, Tan I, Leung T, SundarRaj N. Rho-mediated assembly of stress fibers is differentially regulated in corneal fibroblasts and myofibroblasts. Exp Cell Res. 2004;298:574-583.
49. He J, Bazan HE. Epidermal growth factor synergism with TGFbeta1 via PI-3 kinase activity in corneal keratocyte differentiation. Invest Ophthalmol Vis Sci. 2008;49:2936-2945.
50. Imanaka-Yoshida K, Hiroe M, Yoshida T. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Histopathol. 2004;19:517-525.
51. White B. Evaluation and management of pulmonary fibrosis in scleroderma. Curr Rheumatol Rep. 2002;4:108-112.
52. Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol. 1997;235:222-229.
53. Tervo K, van Setten GB, Beuerman RW, Virtanen I, Tarkkanen A, Tervo T. Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy: immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci. 1991;32:2912-2918.
54. Ljubimov AV, Saghizadeh M, Pytela R, Sheppard D, Kenney MC. Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas J Histochem Cytochem. 2001; 49:1341-1350.
55. Kenney MC, Zorapapel N, Atilano S, Chwa M, Ljubimov A, Brown D. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) modulate tenascin-C and fibrillin-1 in bullous keratopathy stromal cells in vitro Exp Eye Res. 2003;77:537-546.